| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/09/2003 | WO2002032946A8 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae |
| 01/09/2003 | WO2002026997A3 Dsp-16 dual-specificity phosphatase |
| 01/09/2003 | WO2002014485A3 Kallikrein gene |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | WO2001068134A9 Therapies that improve graft survival, using antibodies against a b7 antigen |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001055333A9 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 01/09/2003 | US20030009018 Novel hemopoietin receptor protein, NR12 |
| 01/09/2003 | US20030009014 Process for selectively isolating IgY antibodies from egg yolk of an anseriform bird and IgY antibodies obtained thereby |
| 01/09/2003 | US20030009013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009012 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009010 As vaccines for therapy and prophylaxis of Haemophilus influenzae infection |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008822 Use of IL-18 inhibitors for the treatment or prevention of sepsis |
| 01/09/2003 | US20030008819 Targeting endothelium for tissue-specific delivery of agents |
| 01/09/2003 | US20030008415 Determination of protein s concentration; obtain ligand, incubate with sample, detect complex formation, determine protein concentration |
| 01/09/2003 | US20030008398 Nucleotide sequences coding polypeptide for use in the treatment of autoimmune and inflammatory diseases |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008366 Polypeptide for use in the treatment of inflammation |
| 01/09/2003 | US20030008355 Nucleotide sequences coding monclonal antibodyfor use as a tool in genetic engineering |
| 01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
| 01/09/2003 | US20030008350 14273 receptor, a novel G-protein coupled receptor |
| 01/09/2003 | US20030008348 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008344 T1R taste receptors and genes encoding same |
| 01/09/2003 | US20030008334 Protein for use in the diagnosis, prevention and treatment of cancer |
| 01/09/2003 | US20030008321 Antibody for use as tool in immunoassay |
| 01/09/2003 | US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 01/09/2003 | US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008293 Detection of polymorphism in preferential nucleotide sequences; obtain cells, extract nucleotide sequences, incubate with probe, detect signal, monitor hybridization pattern |
| 01/09/2003 | US20030008284 Polynucleotides related to colon cancer |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030008274 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of viral diseases |
| 01/09/2003 | US20030007980 Urease-based vaccine and treatment for helicobacter infection |
| 01/09/2003 | US20030007974 Endopeptidase/anti-PSMA antibody fusion proteins for treatment of cancer |
| 01/09/2003 | US20030007973 Mixture containing vaccine |
| 01/09/2003 | US20030007972 Administering tumor necrosis factor inhibitor |
| 01/09/2003 | US20030007971 Interleukin inhibitor |
| 01/09/2003 | US20030007969 Administering integrin antagonist |
| 01/09/2003 | US20030007967 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/09/2003 | DE20213551U1 New monoclonal antibody specific for procollagenase 3, useful for diagnosing breast cancer, rheumatoid arthritis and osteoarthritis |
| 01/09/2003 | CA2452690A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 01/09/2003 | CA2452202A1 Diagnostic methods and agents |
| 01/09/2003 | CA2452196A1 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/09/2003 | CA2452058A1 Bispecific antibodies that bind to vegf receptors |
| 01/09/2003 | CA2451955A1 Antibodies to opgl |
| 01/09/2003 | CA2451854A1 Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof |
| 01/09/2003 | CA2451236A1 Peptides for use as translocation factors |
| 01/08/2003 | EP1273918A2 Method of selecting evolved binding members using a native epitope |
| 01/08/2003 | EP1272663A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 01/08/2003 | EP1272647A1 Multivalent antibodies and uses therefor |
| 01/08/2003 | EP1272641A2 Serine-threonine kinase |
| 01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
| 01/08/2003 | EP1272636A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
| 01/08/2003 | EP1272609A2 Single chain antibody against mutant p53 |
| 01/08/2003 | EP1272527A2 Anti-d monoclonal antibodies |
| 01/08/2003 | EP1272526A1 Enhancement of antibody-mediated immune responses |
| 01/08/2003 | EP1272525A1 Novel antibodies specifically identifying inactive psa, and uses thereof |
| 01/08/2003 | EP1272523A1 Human emr2, a g-protein coupled receptor from the egf-tm7 family |
| 01/08/2003 | EP1272522A1 Selectable marker genes |
| 01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
| 01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272506A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/08/2003 | EP1272214A1 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells |
| 01/08/2003 | EP1272205A1 Sialoadhesin factor-2 antibodies |
| 01/08/2003 | EP1098665B1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/08/2003 | EP0929579B1 Monoclonal antibodies against a human act and serine protease complex |
| 01/08/2003 | CN1390258A Factor IX/factor IXa antibodies and antibody derivatives |
| 01/08/2003 | CN1390256A Novel protein and DNA thereof |
| 01/08/2003 | CN1390233A Antitumor antibodies, proteins, and uses thereof |
| 01/08/2003 | CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use |
| 01/08/2003 | CN1390138A Novel use of antibodies as vaccines |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1389472A Immune conjugate of type-IV collagenase-resisting monoclonal antibody 3D6 and lidamycin for treating colorectal carcinoma and other digestive track tumors |
| 01/07/2003 | WO2002004664A2 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 01/07/2003 | US6504013 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody |
| 01/07/2003 | US6504012 Polyethylene glycol fractionation of impure gamma-globulin, treating with an organic solvent for inactivated envelope viruses, and heat treating to inactivate heat sensitive viruses, removing aggregates generated from heat treatment |
| 01/07/2003 | US6504007 GDNF receptor |
| 01/07/2003 | US6504006 Detecting and measuring the proteolytic activity of botulium type A neurotoxin in an assay are described. Detection is based on an increase in fluorescence due to hydrolysis of these internally quenched fluorescent peptide substrates by |
| 01/07/2003 | US6503736 Antibodies to crosslinkers and methods for using the same |
| 01/07/2003 | US6503733 Polynucleotides which identify and encode NANCH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NANCH and a method for producing NANCH. Agonists, antibodies |
| 01/07/2003 | US6503732 An infectious modified Tobacco Mosaic Virus (TMV) virion comprising a coat protein (CP) or a movement protein (MP) gene is replaced with a nuclear inclusion protease (NIa) expression cassette for the expression of a heterologous |
| 01/07/2003 | US6503706 The invention addresses DNA-protein-complexes, proteins, DNA sequences and antibodies that are suitable for the detection of cells with an unlimited proliferation and tumor-formation potential. The invention further addresses methods for |
| 01/07/2003 | US6503702 Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503511 Derivatives of choline binding proteins for vaccines |
| 01/07/2003 | US6503510 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 01/07/2003 | US6503509 Method for receptor desensitization |
| 01/07/2003 | CA2415199A1 Genes and their genetic products pertinent to microsatellite instable (msi+) tumours |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA1341415C Targeted multifunctional proteins |
| 01/03/2003 | WO2003001212A2 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | WO2003000941A2 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 01/03/2003 | WO2003000931A1 Immunoaffinity isolation of modified peptides from complex mixtures |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000891A2 Protein-protein interactions in the inner ear |